In SEER database, 96.74% of patients were 50 years of age or older. Multivariate Cox analysis revealed that for PCa patients, age at presentation, older age, single marital status, lower socioeconomic status, higher PSA level, T1 and N0 stage, and bone metastasis were independent risk ...
Men living in urban areas were likely to receive definitive treatment for their early-stage prostate cancer than those who living in rural areas10. Education level and neighborhood socio-economic status were independently associated with risk of advanced PCa11. Patients clinical characteristics including...
Emily J. Martin MD, Eric Widera MD, in Medical Clinics of North America, 2020 Cancer Prognosis for early-stage cancer is primarily based on tumor type, disease burden, and aggressiveness suggested by clinical, imaging, laboratory, pathologic, and molecular characteristics. For more advanced cancers...
Obesity has been implicated in the pathogenesis of prostate cancer (1, 2). It has been reported that obesity might play a role also in disease diagnosis and management (2). Obese men have been observed to be less likely to be detected with early-stage disease (2). It has been found ...
Prognostic indicators of disease outcome are stage, pre-therapy PSA level and Gleason score, higher the grade, and the stage poorer the prognosis.Information on the relationship of diet and prostate cancer is poor. American Urological Association(AUA) recommends screening in those of 55 to 69,no...
If cancer is found on biopsy, prognosis and treatment depend on the grade of the cancer cells, the size of the tumor, PSA value, and stage of the cancer, as well as your general health. Grading Grading is a way of rating the cancer cells. Higher scores mean the cells are more abnorma...
We found that this ratio is a prognosticator closely associated to the stage of tumor (local or extensive) and to the chance of death from prostate cancer. Stage, the ratio of positive chips and the Gleason histologic score are all closely tied one to another, and it is unclear from this...
Thus, we developed an objective scoring system to evaluate reliably CD44v6 (Bender Medsystems, Vienna, Austria) as a prognostic marker for prostate cancer. A total of 22 patients with metastatic stage pT3bN0M0 or any pTN1M0 disease and 18 with nonmetastatic disease less than stage pT3bN0M0...
Poor prognosis category Novel prostate cancer classification DESNT prostate cancer Latent Process Decomposition 1. Introduction Risk categories based on prostate-specific antigen (PSA), Gleason score, and Clinical Stage that predict PSA failure [1], underpin the treatment of localized prostate cancer, as...
differential diagnosis and prognosis of prostate cancer Glen Kristiansen Institute of Pathology of the University Hospital Bonn, Bonn, Germany Molecular diagnostics is a rapidly evolving area of surgical pathology, that is gradually beginning to transform our diagnostical procedures for a variety of ...